According to Cancer.Gov, in 2016 there were an estimated 1,685,210 new cases of cancer that were diagnosed in the United States alone. There were over 595,690 who passed way due to the disease. The most common cancers in 2016 were the following:
- Breast Cancer
- Lung & Bronchus Cancer
- Prostate Cancer
- Colon & Rectum Cancer
- Bladder Cancer
- Melanoma of the Skin
- Non-Hodgkin Lymphoma
- Thyroid Cancer
- Kidney & Renal Pelvis Cancer
- Endometrial Cancer
- Pancreatic Cancer
How Does Oncotarget Help Combat These Numbers?
Oncotarget is a peer-reviewed medical journal which helps to make knowledge about these various cancers and others easier for researchers to access. Cancer is a devastating disease that has torn apart families and people’s lives, along with running their quality of life.
One of the challenges of research is experts in their field may not have access to other people’s work that could be beneficial against the uphill battle of this devastating disease. The medical journal is open aspects and covers research in all aspects of oncology.
First established in 2010, the journal was first published by Impact Journals. Editors-in-Chief Andrei V. Gudkov of the Roswell Park Cancer Institute and Mikhail Blagosklonny oversaw the launch of the medical journal. Ever since they’ve expanded their platform to include other aspects of medical research, but have always stuck true to their goal of sharing knowledge in different aspects of oncology. Visit Oncotarget’s profile page at Facebook.
The reason for their dedication stems from the fact researchers may not always have access to insightful, constructive, and punctual publications to compare to their own research. Sharing this journal and making it easier for researchers to access will help them to further their understanding of the disease and perhaps even lead to more effective treatments in the future.